Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Gynaecol Obstet ; 155(1): 132-137, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33368250

ABSTRACT

OBJECTIVE: To determine the relationship between patients with a low body mass index (BMI; calculated as weight in kilograms divided by the square of height in meters) and in vitro fertilization (IVF) outcomes following frozen-thawed embryo transfer (FET). METHODS: Retrospective cohort study including 12 618 women aged 20-46 years with an underweight (<18.5) or normal weight (18.5-24.9) BMI who underwent controlled ovarian stimulation for IVF in a private and academic IVF center between August 2002 and December 2019. RESULTS: Anti-Müllerian hormone, peak estradiol levels, number of MII oocytes, and fertilized oocytes were greater in the underweight group compared with the normal weight group. The total required gonadotropin dose was lower in the underweight patients compared with the normal weight patients. MII, fertilization, blastulation, and euploid rates did not differ before and after adjusting for confounders between BMI groups. In a cohort of 316 patients who underwent preimplantation genetic testing for aneuploidy and single euploid FET, pregnancy loss, pregnancy, clinical pregnancy, and live birth rates before and after controlling for covariates were similar between groups. CONCLUSION: Although there are known fetal growth or obstetrical issues associated in patients with a low BMI, it is reassuring that these risks do not extend to embryologic or clinical outcomes from IVF treatment.


Subject(s)
Embryo Transfer , Fertilization in Vitro , Body Mass Index , Female , Humans , Pregnancy , Pregnancy Rate , Retrospective Studies
2.
Clin Obstet Gynecol ; 56(4): 650-3, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24100599

ABSTRACT

Prevention of osteoporosis should begin in childhood and continue throughout adulthood. Although genetic determinants of muscle and bone mass may offer other therapeutic options in the future, currently, counseling should primarily focus on lifestyle modification including healthy dietary practices and regular exercise. Vitamin supplementation, particularly vitamin D, should be considered to enhance diet based on patient's need. Attention to estrogen status is also important. In addition, patients should be counseled regularly about cigarette cessation and avoiding moderate alcohol intake.


Subject(s)
Health Behavior , Osteoporosis, Postmenopausal/prevention & control , Risk Reduction Behavior , Alcohol Drinking/adverse effects , Alcohol Drinking/prevention & control , Cost of Illness , Dietary Supplements , Exercise , Female , Humans , Osteoporosis, Postmenopausal/etiology , Risk Factors , Smoking Cessation , Vitamin D/therapeutic use , Vitamins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...